Protecting patients with diabetes from impact of COVID-19
Further warning on SGLT2 inhibitor use and DKA risk in COVID-19
Five new cases of euglycemic diabetic ketoacidosis seen in T2D patients with acute COVID-19 illness.
Biomarker HF risk score envisioned as SGLT2 inhibitor lodestar in diabetes
Together, four “easily measured” biomarkers predicted 5-year heart failure risk in patients with diabetes or prediabetes, potentially identifying...
Prioritize COVID-19 vaccination in both types of diabetes, say docs
The study is the first to prospectively evaluate COVID-19 severity factors and death in people with type 1 and type 2 diabetes separately.
Diabetic retinopathy may predict greater risk of COVID-19 severity
“Our study reports the first description of diabetic retinopathy as a potential risk factor for poor COVID-19 outcomes,” said the authors of a new...
Patient health suffers amid pandemic health care shortages
More than half of clinician respondents to a survey said they saw a decline in patient health because of delayed or inaccessible care.
First-of-its kind guideline on lipid monitoring in endocrine diseases
A new guideline from the Endocrine Society calls for heightened awareness of cholesterol management and treatment in endocrine diseases beyond...
Consensus guidelines address inpatient diabetes technology
The comprehensive document aimed at clinicians, hospitals, and researchers covers use of both continuous glucose monitors and automated insulin...
COVID-19 antibody response not reduced with diabetes
Findings provide “cautious optimism” that a COVID-19 vaccine would be expected to work as well in people with diabetes as those without.
Entresto halves renal events in preserved EF heart failure patients
The PARAGON-HF trial of sacubitril/valsartan in patients with heart failure with preserved ejection fraction didn’t meet its primary outcome but...